Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 2
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Full eradication of pre-clinical human papilloma virus-induced tumors by a lentiviral vaccine.
Douguet L, Fert I, Lopez J, Vesin B, Le Chevalier F, Moncoq F, Authié P, Nguyen TM, Noirat A, Névo F, Blanc C, Bourgine M, Hardy D, Anna F, Majlessi L, Charneau P. Douguet L, et al. Among authors: moncoq f. EMBO Mol Med. 2023 Oct 11;15(10):e17723. doi: 10.15252/emmm.202317723. Epub 2023 Sep 7. EMBO Mol Med. 2023. PMID: 37675835 Free PMC article.
A lentiviral vector expressing a dendritic cell-targeting multimer induces mucosal anti-mycobacterial CD4+ T-cell immunity.
Anna F, Lopez J, Moncoq F, Blanc C, Authié P, Noirat A, Fert I, Souque P, Nevo F, Pawlik A, Hardy D, Goyard S, Hudrisier D, Brosch R, Guinet F, Neyrolles O, Charneau P, Majlessi L. Anna F, et al. Among authors: moncoq f. Mucosal Immunol. 2022 Jun;15(6):1389-1404. doi: 10.1038/s41385-022-00566-z. Epub 2022 Sep 14. Mucosal Immunol. 2022. PMID: 36104497 Free PMC article.
Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models.
Ku MW, Bourgine M, Authié P, Lopez J, Nemirov K, Moncoq F, Noirat A, Vesin B, Nevo F, Blanc C, Souque P, Tabbal H, Simon E, Hardy D, Le Dudal M, Guinet F, Fiette L, Mouquet H, Anna F, Martin A, Escriou N, Majlessi L, Charneau P. Ku MW, et al. Among authors: moncoq f. Cell Host Microbe. 2021 Feb 10;29(2):236-249.e6. doi: 10.1016/j.chom.2020.12.010. Epub 2020 Dec 16. Cell Host Microbe. 2021. PMID: 33357418 Free PMC article.
An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa.
Vesin B, Lopez J, Noirat A, Authié P, Fert I, Le Chevalier F, Moncoq F, Nemirov K, Blanc C, Planchais C, Mouquet H, Guinet F, Hardy D, Vives FL, Gerke C, Anna F, Bourgine M, Majlessi L, Charneau P. Vesin B, et al. Among authors: moncoq f. Mol Ther. 2022 Sep 7;30(9):2984-2997. doi: 10.1016/j.ymthe.2022.04.016. Epub 2022 Apr 27. Mol Ther. 2022. PMID: 35484842 Free PMC article.
Brain cross-protection against SARS-CoV-2 variants by a lentiviral vaccine in new transgenic mice.
Ku MW, Authié P, Bourgine M, Anna F, Noirat A, Moncoq F, Vesin B, Nevo F, Lopez J, Souque P, Blanc C, Fert I, Chardenoux S, Lafosse L, Cussigh D, Hardy D, Nemirov K, Guinet F, Langa Vives F, Majlessi L, Charneau P. Ku MW, et al. Among authors: moncoq f. EMBO Mol Med. 2021 Dec 7;13(12):e14459. doi: 10.15252/emmm.202114459. Epub 2021 Oct 25. EMBO Mol Med. 2021. PMID: 34647691 Free PMC article.